Title:
COMPOSITION FOR TREATMENT OF SKIN
Document Type and Number:
WIPO Patent Application WO/2011/161465
Kind Code:
A3
Abstract:
A composition comprising (i) stearidonic acid, or an ester thereof, and optionally (ii) conjugated octadecatrienoic acid or an ester thereof for use in the stimulation of sirtuin synthesis in skin cells.
Inventors:
COUPLAND KEITH (GB)
Application Number:
PCT/GB2011/051191
Publication Date:
August 23, 2012
Filing Date:
June 24, 2011
Export Citation:
Assignee:
SEEDS GROUP LP (US)
COUPLAND KEITH (GB)
COUPLAND KEITH (GB)
International Classes:
A61K8/36; A61K8/97; A61K8/37; A61K8/92; A61K31/202; A61K36/30; A61Q17/00; A61Q17/04; A61Q19/00; A61Q19/08
Domestic Patent References:
| WO2010013015A2 | 2010-02-04 |
Foreign References:
| US20080213357A1 | 2008-09-04 | |||
| US6340485B1 | 2002-01-22 |
Other References:
MOREAU, M. ET AL.: "Enhancing cell longevity for cosmetic applications: a complimentary approach", J DRUGS DERMATOL, vol. 6, no. 6, June 2007 (2007-06-01), pages 14 - 19, XP009144734
CONG CAO ET AL: "SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, UNIVERSITY PRESS CAROL DAVILA, BUCHAREST, RO, vol. 13, no. 9B, 1 September 2009 (2009-09-01), pages 3632 - 3643, XP009160306, ISSN: 1582-1838, [retrieved on 20080804], DOI: 10.1111/J.1582-4934.2008.00453.X
CONG CAO ET AL: "SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, UNIVERSITY PRESS CAROL DAVILA, BUCHAREST, RO, vol. 13, no. 9B, 1 September 2009 (2009-09-01), pages 3632 - 3643, XP009160306, ISSN: 1582-1838, [retrieved on 20080804], DOI: 10.1111/J.1582-4934.2008.00453.X
Attorney, Agent or Firm:
TOLLETT, Ian (11 Staple Inn BuildingsLondon, Greater London WC1V 7QH, GB)
Download PDF:
Previous Patent: VOLATILE LIQUID EMANATION DEVICE WITH CAPILLARY
Next Patent: PLANT EUKARYOTIC TRANSLATION INITIATION FACTOR 4E
Next Patent: PLANT EUKARYOTIC TRANSLATION INITIATION FACTOR 4E